235 related articles for article (PubMed ID: 18451265)
1. A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels.
Bouatia-Naji N; Rocheleau G; Van Lommel L; Lemaire K; Schuit F; Cavalcanti-Proença C; Marchand M; Hartikainen AL; Sovio U; De Graeve F; Rung J; Vaxillaire M; Tichet J; Marre M; Balkau B; Weill J; Elliott P; Jarvelin MR; Meyre D; Polychronakos C; Dina C; Sladek R; Froguel P
Science; 2008 May; 320(5879):1085-8. PubMed ID: 18451265
[TBL] [Abstract][Full Text] [Related]
2. Genetic and functional assessment of the role of the rs13431652-A and rs573225-A alleles in the G6PC2 promoter that are strongly associated with elevated fasting glucose levels.
Bouatia-Naji N; Bonnefond A; Baerenwald DA; Marchand M; Bugliani M; Marchetti P; Pattou F; Printz RL; Flemming BP; Umunakwe OC; Conley NL; Vaxillaire M; Lantieri O; Balkau B; Marre M; Lévy-Marchal C; Elliott P; Jarvelin MR; Meyre D; Dina C; Oeser JK; Froguel P; O'Brien RM
Diabetes; 2010 Oct; 59(10):2662-71. PubMed ID: 20622168
[TBL] [Abstract][Full Text] [Related]
3. Multiple functional polymorphisms in the G6PC2 gene contribute to the association with higher fasting plasma glucose levels.
Baerenwald DA; Bonnefond A; Bouatia-Naji N; Flemming BP; Umunakwe OC; Oeser JK; Pound LD; Conley NL; Cauchi S; Lobbens S; Eury E; Balkau B; Lantieri O; ; Dadi PK; Jacobson DA; Froguel P; O'Brien RM
Diabetologia; 2013 Jun; 56(6):1306-16. PubMed ID: 23508304
[TBL] [Abstract][Full Text] [Related]
4. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
Tam CH; Ho JS; Wang Y; Lee HM; Lam VK; Germer S; Martin M; So WY; Ma RC; Chan JC; Ng MC
PLoS One; 2010 Jul; 5(7):e11428. PubMed ID: 20628598
[TBL] [Abstract][Full Text] [Related]
5. The impact of genetic variation in the G6PC2 gene on insulin secretion depends on glycemia.
Heni M; Ketterer C; Hart LM; Ranta F; van Haeften TW; Eekhoff EM; Dekker JM; Boomsma DI; Nijpels G; Kramer MH; Diamant M; Simonis-Bik AM; Heine RJ; de Geus EJ; Schäfer SA; Machicao F; Ullrich S; Thamer C; Stefan N; Staiger H; Häring HU; Fritsche A
J Clin Endocrinol Metab; 2010 Dec; 95(12):E479-84. PubMed ID: 20826583
[TBL] [Abstract][Full Text] [Related]
6. Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11).
Zusi C; Rinaldi E; Bonetti S; Boselli ML; Trabetti E; Malerba G; Bonora E; Bonadonna RC; Trombetta M
J Endocrinol Invest; 2021 Dec; 44(12):2567-2574. PubMed ID: 34128214
[TBL] [Abstract][Full Text] [Related]
7. Additive effects of genetic variation in GCK and G6PC2 on insulin secretion and fasting glucose.
Li X; Shu YH; Xiang AH; Trigo E; Kuusisto J; Hartiala J; Swift AJ; Kawakubo M; Stringham HM; Bonnycastle LL; Lawrence JM; Laakso M; Allayee H; Buchanan TA; Watanabe RM
Diabetes; 2009 Dec; 58(12):2946-53. PubMed ID: 19741163
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk.
Reiling E; van 't Riet E; Groenewoud MJ; Welschen LM; van Hove EC; Nijpels G; Maassen JA; Dekker JM; 't Hart LM
Diabetologia; 2009 Sep; 52(9):1866-70. PubMed ID: 19533084
[TBL] [Abstract][Full Text] [Related]
9. Common genetic determinants of glucose homeostasis in healthy children: the European Youth Heart Study.
Kelliny C; Ekelund U; Andersen LB; Brage S; Loos RJ; Wareham NJ; Langenberg C
Diabetes; 2009 Dec; 58(12):2939-45. PubMed ID: 19741166
[TBL] [Abstract][Full Text] [Related]
10. Glucose-6-phosphatase catalytic subunit 2 negatively regulates glucose oxidation and insulin secretion in pancreatic β-cells.
Rahim M; Nakhe AY; Banerjee DR; Overway EM; Bosma KJ; Rosch JC; Oeser JK; Wang B; Lippmann ES; Jacobson DA; O'Brien RM; Young JD
J Biol Chem; 2022 Apr; 298(4):101729. PubMed ID: 35176280
[TBL] [Abstract][Full Text] [Related]
11. Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes.
Shi Y; Li Y; Wang J; Wang C; Fan J; Zhao J; Yin L; Liu X; Zhang D; Li L
PLoS One; 2017; 12(7):e0181232. PubMed ID: 28704540
[TBL] [Abstract][Full Text] [Related]
12. Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion.
Hu C; Zhang R; Wang C; Yu W; Lu J; Ma X; Wang J; Jiang F; Tang S; Bao Y; Xiang K; Jia W
PLoS One; 2010 Jul; 5(7):e11761. PubMed ID: 20668700
[TBL] [Abstract][Full Text] [Related]
13. Additive genetic effect of GCKR, G6PC2, and SLC30A8 variants on fasting glucose levels and risk of type 2 diabetes.
Chen G; Shriner D; Zhang J; Zhou J; Adikaram P; Doumatey AP; Bentley AR; Adeyemo A; Rotimi CN
PLoS One; 2022; 17(6):e0269378. PubMed ID: 35657990
[TBL] [Abstract][Full Text] [Related]
14. A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population.
Hu C; Zhang R; Wang C; Ma X; Wang C; Fang Q; Bao Y; Xiang K; Jia W
Diabetologia; 2009 Mar; 52(3):451-6. PubMed ID: 19082990
[TBL] [Abstract][Full Text] [Related]
15. Nonsynonymous single-nucleotide polymorphisms in the G6PC2 gene affect protein expression, enzyme activity, and fasting blood glucose.
Overway EM; Bosma KJ; Claxton DP; Oeser JK; Singh K; Breidenbach LB; Mchaourab HS; Davis LK; O'Brien RM
J Biol Chem; 2022 Feb; 298(2):101534. PubMed ID: 34954144
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic islet beta cell-specific deletion of G6pc2 reduces fasting blood glucose.
Bosma KJ; Rahim M; Singh K; Goleva SB; Wall ML; Xia J; Syring KE; Oeser JK; Poffenberger G; McGuinness OP; Means AL; Powers AC; Li WH; Davis LK; Young JD; O'Brien RM
J Mol Endocrinol; 2020 May; 64(4):235-248. PubMed ID: 32213654
[TBL] [Abstract][Full Text] [Related]
17. G6PC2 confers protection against hypoglycemia upon ketogenic diet feeding and prolonged fasting.
Bosma KJ; Rahim M; Oeser JK; McGuinness OP; Young JD; O'Brien RM
Mol Metab; 2020 Nov; 41():101043. PubMed ID: 32569842
[TBL] [Abstract][Full Text] [Related]
18. G6PC2: a negative regulator of basal glucose-stimulated insulin secretion.
Pound LD; Oeser JK; O'Brien TP; Wang Y; Faulman CJ; Dadi PK; Jacobson DA; Hutton JC; McGuinness OP; Shiota M; O'Brien RM
Diabetes; 2013 May; 62(5):1547-56. PubMed ID: 23274894
[TBL] [Abstract][Full Text] [Related]
19. Association of a common G6PC2 variant with fasting plasma glucose levels in non-diabetic individuals.
Demirci FY; Dressen AS; Hamman RF; Bunker CH; Kammerer CM; Kamboh MI
Ann Nutr Metab; 2010; 56(1):59-64. PubMed ID: 20029179
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function.
Staiger H; Machicao F; Schäfer SA; Kirchhoff K; Kantartzis K; Guthoff M; Silbernagel G; Stefan N; Häring HU; Fritsche A
PLoS One; 2008; 3(12):e3962. PubMed ID: 19088850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
